So far I enjoy this board better than IHub. Personally, I like to read both positive and negative information on CYDY (aka good DD) as it gives a well rounded view. If the view is only one sided or extremely positive or negative, it gets out of hand. IH is somewhere in the middle. Leronlimab has a very promising future, but as usual, the the two “Fs”, FDA and funding, slow and complicate the process. I found CYDY a number of years ago so my average is a little higher, but I’ve purchased more shares to lower my cost. Hopefully in the next 12-24 months will finally see a nice PPS and CYDY will get on one of the large exchanges.